Agilent Technologies Inc. demonstrates a solid business model with strong competitive advantages and market positioning, particularly through its innovative product offerings and commitment to operational efficiency. However, it faces challenges related to funding uncertainties and currency fluctuations that could impact future growth. The company's growth prospects remain robust, particularly in the PFAS and food markets, yet cautious guidance reflects potential economic headwinds.
Analysis Date: February 26, 2025 Last Updated: June 1, 2025
+200%
+11.6% per year
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
CountryUS
ExchangeNYSE
IndustryMedical - Diagnostics & Research
SectorHealthcare
Market Cap$39.14B
CEOMr. Rodney Gonsalves
Agilent Technologies, Inc. is a company that makes tools and equipment used in science and healthcare. They create products that help scientists and doctors study living things, test for diseases, and analyze chemicals. Their offerings include machines that analyze DNA, liquids, and other samples, as well as software to help manage data. Agilent sells their products to labs and healthcare facilities around the world, helping improve research and diagnostics.
Streams of revenue
Cloud Services:40%
Software Licensing:24%
Consulting Services:16%
Hardware Sales:12%
Support Services:8%
Estimations for reference only
Geographic Distribution
Americas:38%
Europe:31%
Asia-Pacific:25%
Middle East & Africa:6%
Estimations for reference only
Core Products
🧬
DNA SequencingFor genetic analysis
📊
Flow CytometryCell analysis technology
🔬
Mass SpectrometryAnalyzes molecular composition
🤖
Laboratory AutomationAutomates lab processes
🧪
Liquid ChromatographyUsed for chemical analysis
💾
Genetic Data ManagementOrganizes genetic info
🔗
Oligonucleotide SynthesisCustom DNA sequences
Business Type
Business to Business
Competitive Advantages
Unlock Competitive Advantages Analysis
Discover all competitive advantages and strategic moats that protect A's market position.
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Graham Value Metrics
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
📊
Unlock Graham value analysis
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Income Statement Flow
Scroll horizontally to see more
About Profitability Metrics
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
📊
Unlock Profitability Metrics
Access detailed profitability metrics with visual gauges and benchmarks
A Stock Analysis: Agilent Technologies, Inc. Investment Guide
A (Agilent Technologies, Inc.) is a Healthcare company listed on New York Stock Exchange. The stock has generated 11.6% annual returns with an overall investment score of None/100.
Agilent Technologies Inc. demonstrates a solid business model with strong competitive advantages and market positioning, particularly through its innovative product offerings and commitment to operational efficiency. However, it faces challenges related to funding uncertainties and currency fluctuations that could impact future growth. The company's growth prospects remain robust, particularly in the PFAS and food markets, yet cautious guidance reflects potential economic headwinds.
A Key Financial Metrics
A financial analysis includes comprehensive valuation ratios, profitability metrics, and financial health indicators. The company has a valuation score of 0.8914014317138088/100 and profitability score of 5.0/100 with financial health rated 8.8/100.
About Agilent Technologies, Inc.
Agilent Technologies, Inc. is a company that makes tools and equipment used in science and healthcare. They create products that help scientists and doctors study living things, test for diseases, and analyze chemicals. Their offerings include machines that analyze DNA, liquids, and other samples, as well as software to help manage data. Agilent sells their products to labs and healthcare facilities around the world, helping improve research and diagnostics.
A Investment Recommendation
Based on our comprehensive analysis of A, investors should consider the company's strong performance track record, earnings consistency (10/10 quarters beat expectations), and current valuation metrics when making investment decisions.
Healthcare Sector Analysis
A operates in the Medical - Diagnostics & Research industry within the Healthcare sector. This analysis compares Agilent Technologies, Inc. performance against industry and sector benchmarks to provide context for investment decisions.
Frequently Asked Questions about A Stock
Is A a good investment?
A (Agilent Technologies, Inc.) has generated 11.6% annual returns with an overall score of None/100. Agilent Technologies Inc. demonstrates a solid business model with strong competitive advantages and market positioning, particularly through its innovative product offerings and commitment to operational efficiency. However, it faces challenges … Investors should consider their risk tolerance and investment goals when evaluating A.
What is A P/E ratio and valuation?
A valuation metrics including P/E ratio, price-to-book ratio, and price-to-sales ratio are analyzed on this page with comparisons to Medical - Diagnostics & Research industry and Healthcare sector benchmarks. The company currently has a valuation score of 0.8914014317138088/100.
Should I buy A stock now?
The decision to buy A stock should be based on comprehensive analysis of financial metrics, market conditions, and individual investment goals. Our analysis provides profitability score of 5.0/100, financial health score of 8.8/100, and detailed performance metrics to help inform your investment decision.
What are A financial health indicators?
A financial health analysis includes liquidity ratios, debt levels, cash flow metrics, and profitability indicators. The company has a financial health score of 8.8/100 based on comprehensive analysis of balance sheet strength and operational efficiency.
How does A compare to competitors?
A performance is benchmarked against Medical - Diagnostics & Research industry peers and Healthcare sector averages. Our analysis includes comparative valuation ratios, profitability metrics, and growth indicators to provide context for Agilent Technologies, Inc.'s market position.
What are A historical returns?
A has generated 11.6% annual returns over the 10Y. Historical performance analysis includes price appreciation, dividend yields, and total shareholder returns compared to market benchmarks.
A Key Investment Metrics Summary
Annual Return: 11.6%
Valuation Score: 0.8914014317138088/100
Profitability Score: 5.0/100
Financial Health Score: 8.8/100
Growth Score: 4.897547157692663/100
Earnings Beat Rate: 10/10 quarters
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: New York Stock Exchange
Market Cap: 39137938800
A Investment Thesis
Agilent Technologies, Inc. (A) represents a strong investment opportunity in the Healthcare sector. With an overall score of None/100, the company demonstrates areas for financial improvement.
Investment Strengths
Moderate Price-to-Earnings Ratio
Strong Price-to-Sales Ratio
Strong Return on Equity
Robust Net Profit Margin
Healthy Current Ratio
Reasonable Debt Levels
Strong Customer Focus and Innovation
Diverse Product Offerings and Market Leadership
Operational Efficiency and Cost Management
Growth Potential in PFAS and Food Markets
Strong Order Book and Market Recovery
Innovation and New Product Launches
Investment Risks
High EV/EBITDA Ratio
High Price-to-Cash Flow Ratio
Moderate Gross Profit Margin
Operating Profit Margin Limitations
Negative Interest Coverage
Limited Cash Reserves
Dependence on External Funding
Challenges in Academia and Government Markets
Currency Headwinds Impacting Revenue
Potential Economic Uncertainties
We use cookies to analyze site traffic and optimize your site experience.
By accepting, you consent to our use of cookies. Read our Privacy Policy to Learn more.
